US based Agilent Technologies Inc. and Cartagenia has announced that they have signed a definitive agreement under which Agilent will acquire Cartagenia, a leading provider of software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays.
The acquisition is expected to be completed May 19, subject to local laws and regulations and customary closing conditions. Cartagenia employs 36 people, all of whom will be offered employment with Agilent.
Financial terms of the transaction were not disclosed.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
